NOPHO - ALL 2008. Treatment Protocol for Children (1.0 - 17.9 years of age) with Acute Lymphoblastic Leukemia - NOPHO ALL-2008

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2008-003235-20-IS

Enrollment

Registered

2009-09-14

Start date

2010-01-07

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALL

Interventions

Trade Name: Depocyte Product Name: Dypocyte Pharmaceutical Form: Injection* Trade Name: Methotrexate Product Name: Methotrexate Pharmaceutical Form: Intravenous infusion Trade Name: Asparaginase Pha

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Denmark, Finland, Iceland, Lithuania, Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026